Osteopontin promotes tumor microenvironment remodeling and therapy resistance
Cancer Letters · 2025-05 · 617 · 217618
DOI: 10.1016/j.canlet.2025.217618 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Letters, 2025-05. Verfasst von Chao Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Maxillofacial and Otorhinolaryngological Oncology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research C…. Hauptthemen laut MEDLINE: Osteopontin, Tumor Microenvironment, Neoplasms, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 140 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Maxillofacial and Otorhinolaryngological Oncology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianj…
- Key Laboratory of Basic and Translational Medicine on Head & Neck Cancer, Tianjin, 300060, China; State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin, 300060, China; Department…
Zitieren
APA
Liu, C., Xia, S., Wang, B., Li, J., Wang, X., Ren, Y., & Zhou, X. (2025). Osteopontin promotes tumor microenvironment remodeling and therapy resistance. Cancer Letters, 617, 217618. https://doi.org/10.1016/j.canlet.2025.217618
Vancouver
Liu C, Xia S, Wang B, Li J, Wang X, Ren Y, et al. Osteopontin promotes tumor microenvironment remodeling and therapy resistance. Cancer Letters. 2025;617:217618. doi:10.1016/j.canlet.2025.217618
BibTeX
@article{Liu2025,
author = {Liu, Chao and Xia, Shunjin and Wang, Bo and Li, Jiayong and Wang, Xuyan and Ren, Yu and Zhou, Xuan},
title = {Osteopontin promotes tumor microenvironment remodeling and therapy resistance},
journal = {Cancer Letters},
year = {2025},
volume = {617},
pages = {217618},
doi = {10.1016/j.canlet.2025.217618}
}
EUVIMED